%D8%B3%D9%8A%D9%81%D8%A7%D9%84%D9%83%D8%B3%D9%8A%D9%86%D8%B3%D9%81%D8%A7%D9%84%DA%A9%D8%B3%DB%8C%D9%86Category:CefalexinCeffalecsinCefalexinCefalexinCefalexina%D8%B3%D9%81%D8%A7%D9%84%DA%A9%D8%B3%DB%8C%D9%86KefaleksiiniC%C3%A9falexineCefalexina%E0%A4%B8%E0%A5%87%E0%A4%AB%E0%A4%BE%E0%A4%B2%E0%A5%87%E0%A4%95%E0%A5%8D%E0%A4%B8%E0%A4%BF%E0%A4%A8SefaleksinCefalexina%E3%82%BB%E3%83%95%E3%82%A1%E3%83%AC%E3%82%AD%E3%82%B7%E3%83%B3%EC%84%B8%ED%8C%94%EB%A0%89%EC%8B%A0CefalexineCefalexina%E0%AC%B8%E0%AD%87%E0%AC%AB%E0%AC%BE%E0%AC%B2%E0%AD%87%E0%AC%95%E0%AD%8D%E2%80%8C%E0%AC%B8%E0%AC%BF%E0%AC%A8%E0%AD%8DCefaleksynaCefalexinaCefalexin%C4%83%D0%A6%D0%B5%D1%84%D0%B0%D0%BB%D0%B5%D0%BA%D1%81%D0%B8%D0%BDCefaleksinCefalexinCefaleksinCefaleksinCefalexin%E0%B9%80%E0%B8%8B%E0%B8%9F%E0%B8%B2%E0%B9%80%E0%B8%A5%E0%B8%81%E0%B8%8B%E0%B8%B4%E0%B8%99Sefaleksin%D0%A6%D0%B5%D1%84%D0%B0%D0%BB%D0%B5%D0%BA%D1%81%D0%B8%D0%BDCefalexinQ411417%E9%A0%AD%E5%AD%A2%E6%B0%A8%E8%8B%84
about
sameAs
Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin CapsulesCross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin SuspensionExamination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract InfectionsThe Placebo Effect May Involve Modulating Drug BioavailabilityAntibiotics for Prevention of SSI in Obese Women Undergoing CSComparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic UseCefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal InfectionsPrevention of Arrhythmia Device Infection Trial (PADIT) (2012-12-31)Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
P4844
Epitope analysis of aztreonam by antiaztreonam monoclonal antibodies and possible consequences in beta-lactams hypersensitivityDrugs as allergens: an immunoassay for detecting IgE antibodies to cephalosporinsCross-reactivity in β-Lactam Allergy.Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infections.beta-Lactam allergenic determinants: fine structural recognition of a cross-reacting determinant on benzylpenicillin and cephalothin.Synthesis, characterization and immunochemical evaluation of cephalosporin antigenic determinants.Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial.Modified silica matrices for controlled release of cephalexin.Quantitative analysis of cefalexin based on artificial neural networks combined with modified genetic algorithm using short near-infrared spectroscopy.Three-ways crossover bioequivalence study of cephalexin in healthy Malay volunteers.Short-term stability studies of ampicillin and cephalexin in aqueous solution and human plasma: Application of least squares method in Arrhenius equation.Controlled release of antimicrobial Cephalexin drug from silica microparticles.Reaction with, and fine structural recognition of polyamines by human IgE antibodiesCephalexin remains the preferred antibiotic for uncomplicated cellulitis: revisited
P921
Q18975220-AC5F9BE6-E4AD-45E2-9FDF-8AF073C25641Q19597369-C5166B36-9C93-49BB-BB71-236EE07691A8Q2085267-86617BDC-2356-44C1-81FB-7BCCA7F279EEQ221668-5E6D84D1-0882-4BBD-8DF3-B8B160680541Q2622199-882738DD-463B-4C25-87D7-119FA971B29DQ34879-83F1994E-5961-49DA-965A-E23838C53789Q3776920-CFB35179-9741-4205-A77B-31D114C91B79Q55779861-A6E6D2BF-4F17-4AC9-B50E-DC8ECBD8194DQ876887-E1C2B879-6239-470B-B91F-1F01CBC7F989
P2176
Q61938446-5AB4023B-AAE0-4D8A-B547-15EC2E9D6DC5Q61938449-4E48C0F4-585F-46B6-B37C-F4C083215BACQ61956654-B660DC99-042D-417E-9A5C-A21FC2577527Q61957559-3C816D47-B820-4FC2-AEBF-96DD00A940DFQ62035514-1919ECAF-B8DF-4FF3-AD49-11663F9B0FEEQ63316340-8F3A3F2C-B65D-47B8-8AB9-909B346A3FF8Q63585464-866FE13E-A40A-4EC6-A575-F9B6E330F7DBQ86168989-81708EFB-74B5-4F62-9659-B10D94A7C9F4Q87932704-26553654-C256-4BEA-9F62-28D9EC24635E
P4844
Q28316455-C67ACBF1-CB59-4C3A-A163-BD87024D1EA4Q28328776-504A0706-2387-4A54-9AD1-57A5BD956FAEQ41987583-31E2FDC7-C0C3-481B-929C-C59C8B5CD15BQ42256969-586B83DC-D58F-4956-B591-1A767CC1E036Q44304330-5873EE15-A924-4CFB-A3F2-5A5552A32ECCQ44496116-C35FF6D7-AE41-4B2C-9F50-736500CDDC45Q45247343-DFE0ADF8-CC87-45CF-8CE5-E6BCAF2D1ACDQ45326517-285CBC24-BD95-473F-A3A8-8B0354A0A5C8Q45399379-4662C38B-8752-432C-864F-DD8C2D927A4BQ51340242-3E93B857-52CE-4A19-8202-CDEB946DEF16Q51371458-C3E4F369-7340-44E5-A8AC-F0D8F21CBEFBQ53666550-96A5D844-987C-476B-85CF-232DFB1DCCB2Q74128120-0F6CAD9A-1316-4B9B-BB1C-7BDB97BEDE99Q87316960-BF601379-0CA8-4C29-B9FA-FA1B48BD90CD
P921
description
Antibiyotik
@tr
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
name
Cefaleksin
@sh
Cefaleksin
@sl
Cefaleksin
@sr-el
Cefalexin
@de
Cefalexin
@ro
Cefalexin
@sv
Cefalexina
@ca
Cefalexina
@es
Cefalexina
@gl
Cefalexina
@oc
type
label
Cefaleksin
@sh
Cefaleksin
@sl
Cefaleksin
@sr-el
Cefalexin
@de
Cefalexin
@ro
Cefalexin
@sv
Cefalexina
@ca
Cefalexina
@es
Cefalexina
@gl
Cefalexina
@oc
altLabel
(6R,7R)-7-{[(2R)-2-amino-2-phe ...... .0]oct-2-ene-2-carboxylic acid
@en
15686-71-2
@fr
7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid
@en
7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
@cy
7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
@en
Anhydrous cefalexin
@en
Anhydrous cephalexin
@en
C16H17N3O4S
@fr
C16H17N3O4S1
@it
CEX
@cy
prefLabel
Cefaleksin
@sh
Cefaleksin
@sl
Cefaleksin
@sr-el
Cefalexin
@de
Cefalexin
@ro
Cefalexin
@sv
Cefalexina
@ca
Cefalexina
@es
Cefalexina
@gl
Cefalexina
@oc